Our Compounds
Each compound is third-party verified for purity. Lyophilized and sealed for maximum stability.
Retatrutide is a pioneering triple hormone receptor agonist that simultaneously activates GIP, GLP-1, and glucagon receptors — a unique mechanism that separates it from all dual-agonist compounds. By engaging all three pathways at once, research suggests it may drive substantial reductions in visceral and subcutaneous adipose tissue, improve glycemic homeostasis, and increase resting energy expenditure. Early data has shown markedly greater effects on body mass reduction and metabolic remodeling than single or dual agonist predecessors. Its triple-receptor profile makes it one of the most compelling metabolic peptides in a generation of research.
GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide found in human plasma that has been extensively studied for its profound role in tissue remodeling and cellular regeneration. Research shows it stimulates collagen and glycosaminoglycan synthesis, activates wound-healing gene cascades, and modulates inflammatory signaling. Of particular scientific interest is its ability to influence over 4,000 human genes — effectively resetting the activity patterns of aging cells toward a more youthful expression profile. It also promotes antioxidant enzyme upregulation and angiogenesis, positioning it as a cornerstone compound in anti-aging, dermatological, and regenerative biology research.
A powerful synergistic recovery blend combining two of the most researched peptides in sports and regenerative medicine. BPC-157 (Body Protection Compound 157) is a 15-amino acid peptide derived from human gastric juice, studied for its remarkable systemic healing effects on tendons, ligaments, gut mucosa, muscle, bone, and the CNS. It accelerates angiogenesis and upregulates growth hormone receptors at injury sites. TB-500 (Thymosin Beta-4) is a 43-amino acid peptide that regulates actin — a structural protein critical to cell mobility and repair. It promotes cell migration to sites of damage, suppresses pro-inflammatory cytokines, and enhances flexibility and systemic recovery. Together they address tissue repair from complementary biological angles, making this blend the definitive choice for injury recovery and healing research.
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that stimulates the pituitary to secrete endogenous growth hormone in a pulsatile, physiologically natural pattern — preserving the body's own feedback loop rather than bypassing it the way exogenous GH does. Research has demonstrated its potent effects on visceral adipose tissue reduction, IGF-1 optimization, and lean mass preservation. Beyond body composition, it is being actively investigated for cognitive applications: studies in aging populations show improvements in memory, processing speed, and executive function, with emerging evidence of neuroprotective effects. Its mechanism of action and favorable safety profile make it one of the most clinically relevant GHRH compounds available for research.
Ipamorelin is a selective fifth-generation growth hormone releasing peptide (GHRP) and ghrelin receptor agonist that triggers precise, clean pulses of GH release without meaningfully elevating cortisol, prolactin, or ACTH — a critical advantage over older GHRPs like GHRP-2 and GHRP-6. This selectivity allows researchers to study GH optimization in isolation without the confounding hormonal noise of less selective compounds. Research highlights its role in enhancing lean muscle development, accelerating fat oxidation, deepening slow-wave sleep, and supporting systemic recovery. When paired with Tesamorelin (a GHRH), Ipamorelin creates a powerful synergistic GH pulse — the GHRH primes the pituitary while the GHRP amplifies output, producing significantly greater combined effect than either alone.
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a groundbreaking 16-amino acid peptide encoded within the mitochondrial genome — a rare and remarkable property that has opened entirely new frontiers in bioenergetics and longevity science. Under metabolic stress, MOTS-c translocates from the mitochondria to the cell nucleus, where it directly regulates metabolic gene expression to restore homeostasis. Research has demonstrated its ability to dramatically enhance insulin sensitivity, increase cellular glucose uptake through insulin-independent pathways, activate AMPK signaling, and boost mitochondrial biogenesis. Exercise studies suggest it functions as a cellular exercise mimetic — producing metabolic adaptations in sedentary conditions similar to those triggered by physical training — making it a uniquely compelling target in metabolic, longevity, and performance research.